Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Gross Profit 2020–2022
Elicio Therapeutics Inc. annual/quarterly gross profit history and growth rate from 2020 to 2021. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Elicio Therapeutics Inc. gross profit for the quarter ending September 30, 2021 was 1.5 M, a 204.80% increase year-over-year.
- Elicio Therapeutics Inc. gross profit for the twelve months ending September 30, 2021 was 2.9 M.
- Elicio Therapeutics Inc. annual gross profit for 2022 was 2.3 M, a 91.75% decrease from 2021.
- Elicio Therapeutics Inc. annual gross profit for 2021 was 27.9 M, a 1549.64% increase from 2020.
- Elicio Therapeutics Inc. annual gross profit for 2020 was 1.7 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Elicio Therapeutics Inc. Gross Profit — FAQ
Elicio Therapeutics Inc. (ELTX) gross profit over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Elicio Therapeutics Inc.'s gross profit?
Elicio Therapeutics Inc. (ELTX) reported gross profit of $2M for fiscal 2022.
Where can I see ELTX's gross profit history?
The chart and table above show Elicio Therapeutics Inc.'s gross profit by year and by quarter, including the growth rate.